Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union, as well as in Phase III clinical trials for invasive fungal infections in Japan. The company also provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as in Phase III clinical trials for the treatment of acute bacterial skin and skin structure infections, and Staphylococcus aureus bacteremia. In addition, it engages in developing Derazantinib, a small molecule inhibitor, which is in phase 2 clinical trial for bile duct cancer, as well as in phase ½ clinical trial for bladder and stomach cancer; and Lisavanbulin, a tumor checkpoint controller drug. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Basel, Switzerland. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Basilea Pharmaceutica AG.
Basilea Pharmaceutica AG business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Basilea Pharmaceutica AG are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Basilea Pharmaceutica AG , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Basilea Pharmaceutica AG including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Basilea Pharmaceutica AG and all latest updates of the company are provided.
The 2025 version of Basilea Pharmaceutica AG report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Basilea Pharmaceutica AG- Key Facts
2.2 Basilea Pharmaceutica AG- Geographic Locations
2.3 Basilea Pharmaceutica AG- Subsidiaries and Affiliates
2.4 Basilea Pharmaceutica AG- Business Divisions
2.5 Basilea Pharmaceutica AG- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Basilea Pharmaceutica AG Strategic Analysis Review
3.1 Basilea Pharmaceutica AG- Key Strategies
3.2 Basilea Pharmaceutica AG- Company Outlook Statement
3.3 Basilea Pharmaceutica AG- SWOT Analysis
3.3.1 Basilea Pharmaceutica AG- Key Strengths
3.3.2 Basilea Pharmaceutica AG- Key Weaknesses
3.3.3 Basilea Pharmaceutica AG- Potential Opportunities
3.3.4 Basilea Pharmaceutica AG- Potential Threats
3.4 Basilea Pharmaceutica AG- Key Competitors
4. Business Description of the Company
4.1 Basilea Pharmaceutica AG- Business Overview
4.2 Basilea Pharmaceutica AG- Operations by Segment
5 Products and Services Details
5.1 Basilea Pharmaceutica AG- Key Products
5.2 Basilea Pharmaceutica AG- Key Service Areas
5.3 Basilea Pharmaceutica AG- Key Brands
6 Company Developments
6.1 Basilea Pharmaceutica AG- Company History
6.2 Basilea Pharmaceutica AG- Latest Developments
7 Financial Analysis
7.1 Basilea Pharmaceutica AG- Income Statements
7.2 Basilea Pharmaceutica AG- Balance Sheet
7.3 Basilea Pharmaceutica AG- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Basilea Pharmaceutica AG- Direct Competitors
8.2 Basilea Pharmaceutica AG- Competitor Financial Ratios comparison
8.3 Basilea Pharmaceutica AG- Competitor Stock Charts Comparison
8.4 Basilea Pharmaceutica AG- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
